PDUFA V: Review Model Evaluators Will Observe All FDA-Sponsor Meetings
This article was originally published in The Pink Sheet Daily
Executive Summary
Interim and final assessments will help determine which parts of the new, longer application review help FDA take more first-cycle actions.